Astera Labs, Inc. (NASDAQ:ALAB) Receives $188.17 Average PT from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has earned a consensus recommendation of “Moderate Buy” from the twenty-four research firms that are presently covering the stock, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $188.1667.

A number of equities analysts have recently issued reports on ALAB shares. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, October 8th. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Barclays restated an “equal weight” rating and issued a $155.00 price objective on shares of Astera Labs in a research note on Monday, October 20th. BNP Paribas Exane began coverage on shares of Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating and a $225.00 target price for the company. Finally, Citigroup reissued an “outperform” rating on shares of Astera Labs in a report on Tuesday, December 9th.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 4,620 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the transaction, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. The trade was a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Michael Truett Tate sold 11,430 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the sale, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 576,936 shares of company stock valued at $87,409,540. 12.50% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Assetmark Inc. raised its holdings in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Wexford Capital LP acquired a new position in Astera Labs during the 3rd quarter worth approximately $39,000. National Bank of Canada FI raised its stake in shares of Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares in the last quarter. Pinpoint Asset Management Singapore Pte. Ltd. purchased a new position in shares of Astera Labs during the 3rd quarter worth approximately $47,000. Finally, Whittier Trust Co. acquired a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $55,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

ALAB opened at $179.56 on Wednesday. Astera Labs has a one year low of $47.13 and a one year high of $262.90. The stock has a market capitalization of $30.33 billion, a P/E ratio of 161.77, a price-to-earnings-growth ratio of 2.27 and a beta of 1.50. The business’s 50-day simple moving average is $160.89 and its 200-day simple moving average is $160.42.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business’s revenue was up 103.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts forecast that Astera Labs will post 0.34 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.